ConductScience.org, home

Paper9683296

Matrix metalloproteinase-1 is induced by epidermal growth factor in human bladder tumour cell lines and is detectable in urine of patients with bladder tumours.

Nutt JE and 3 others. Br J Cancer, 1998. Cited by 40 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Matrix metalloproteinase-1 is induced by epidermal growth factor in human bladder tumour cell lines and is detectable in urine of patients with bladder tumours. Papers, record 9683296. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9683296

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Matrix metalloproteinase-1 is induced by epidermal growth factor in human bladder tumour cell lines and is detectable in urine of patients with bladder tumours.
PubMed
Journal
Br J Cancer
PubMed
Year
1998
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
40
iCite
Relative citation ratio, by iCite
0.97
iCite
Revised in PubMed
2019-05-15
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nutt JEJ E
2Mellon JKJ K
3Qureshi KK
4Lunec JJ

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CollagenasesMajor topic
Epidermal Growth FactorMajor topic
Urinary Bladder NeoplasmsMajor topic
Enzyme Induction
ErbB Receptors
Humans
Matrix Metalloproteinase 1
RNA, Messenger
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11302559Urinary type IV collagenase: elevated levels are associated with bladder transitional cell carcinoma.Cancer Epidemiol Biomarkers Prev1992https://conductscience.org/library/papers/1302559PubMed
28320889[Gene expressions of type IV collagenase and tissue inhibitor of metalloproteinases (TIMP) in human bladder cancers].Nihon Hinyokika Gakkai Zasshi1993https://conductscience.org/library/papers/8320889PubMed
38221672Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion.Cancer Res1993https://conductscience.org/library/papers/8221672PubMed
47908215Increased mdr1 gene transcript levels in high-grade carcinoma of the bladder determined by quantitative PCR-based assay.Br J Cancer1994https://conductscience.org/library/papers/7908215PubMed
57911031Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis.Br J Cancer1994https://conductscience.org/library/papers/7911031PubMed
68207529Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors.J Neurosurg1994https://conductscience.org/library/papers/8207529PubMed
78015608A matrix metalloproteinase expressed on the surface of invasive tumour cells.Nature1994https://conductscience.org/library/papers/8015608PubMed
87924696Flow cytometric method for the measurement of epidermal growth factor receptor and comparison with the radio-ligand binding assay.Cytometry1994https://conductscience.org/library/papers/7924696PubMed
96312838A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.Anal Biochem1983https://conductscience.org/library/papers/6312838PubMed
106326095Genomic sequencing.Proc Natl Acad Sci U S A1984https://conductscience.org/library/papers/6326095PubMed
11303735512-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5'-flanking region.Mol Cell Biol1987https://conductscience.org/library/papers/3037355PubMed
122820711Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor.EMBO J1987https://conductscience.org/library/papers/2820711PubMed
132115124Epidermal growth factor stimulation of stromelysin mRNA in rat fibroblasts requires induction of proto-oncogenes c-fos and c-jun and activation of protein kinase C.Mol Cell Biol1990https://conductscience.org/library/papers/2115124PubMed
142226349Metabolism and effects of epidermal growth factor and related growth factors in mammals.Endocr Rev1990https://conductscience.org/library/papers/2226349PubMed
151703045Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation.Cell1991https://conductscience.org/library/papers/1703045PubMed
161911215Phorbol ester and bryostatin effects on growth and the expression of oestrogen responsive and TGF-beta 1 genes in breast tumour cells.Br J Cancer1991https://conductscience.org/library/papers/1911215PubMed
172132731Metalloproteinases and their inhibitors in matrix remodeling.Trends Genet1990https://conductscience.org/library/papers/2132731PubMed
181589913Epidermal growth factor in urine from the patients with urothelial tumors.Urol Int1992https://conductscience.org/library/papers/1589913PubMed
191457364Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas.Br J Cancer1992https://conductscience.org/library/papers/1457364PubMed
207677979Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas.Cancer Res1993https://conductscience.org/library/papers/7677979PubMed

See all 32 referencesDownload CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.

PMIDTitleJournalYearIn PapersSource
41644529Integrative functional genomics analysis identifies pleiotropic genes for vascular diseases.Nat Commun2026https://conductscience.org/library/papers/41644529PubMed
38808816Temozolomide alleviates breast carcinoma via the inhibition of EGFR/ERK/ MMP-1 pathway with induction of apoptotic events.Acta Cir Bras2024https://conductscience.org/library/papers/38808816PubMed
37016361Comprehensive proteomics and platform validation of urinary biomarkers for bladder cancer diagnosis and staging.BMC Med2023https://conductscience.org/library/papers/37016361PubMed
34410940Association of Matrix Metalloproteinase-1 Genotypes With Bladder Cancer Risk.In Vivo2021https://conductscience.org/library/papers/34410940PubMed
29879970Prognostic significance of epidermal growth factor receptor (EGFR) over expression in urothelial carcinoma of urinary bladder.BMC Urol2018https://conductscience.org/library/papers/29879970PubMed
26106137Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesis.Carcinogenesis2015https://conductscience.org/library/papers/26106137PubMed
25866762Bladder carcinoma data with clinical risk factors and molecular markers: a cluster analysis.Biomed Res Int2015https://conductscience.org/library/papers/25866762PubMed
25223345Epidermal growth factor receptor expression in canine transitional cell carcinoma.J Vet Med Sci2015https://conductscience.org/library/papers/25223345PubMed
23487506Transcriptional Modulation of the ERK1/2 MAPK and NF-κB Pathways in Human Urothelial Cells After Trivalent Arsenical Exposure: Implications for Urinary Bladder Cancer.J Can Res Updates2012https://conductscience.org/library/papers/23487506PubMed
22852097Matrix Metalloproteinases and Bladder Cancer: What is New?ISRN Urol2012https://conductscience.org/library/papers/22852097PubMed
22162832Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma.J Exp Med2011https://conductscience.org/library/papers/22162832PubMed
22012889A framework to select clinically relevant cancer cell lines for investigation by establishing their molecular similarity with primary human cancers.Cancer Res2011https://conductscience.org/library/papers/22012889PubMed
21941546Pathobiology and chemoprevention of bladder cancer.J Oncol2011https://conductscience.org/library/papers/21941546PubMed
21487384Matrix metalloproteinases and their clinical relevance in urinary bladder cancer.Nat Rev Urol2011https://conductscience.org/library/papers/21487384PubMed
21344163CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion.Int J Oncol2011https://conductscience.org/library/papers/21344163PubMed
19707309Targeted therapies in the management of metastatic bladder cancer.Biologics2007https://conductscience.org/library/papers/19707309PubMed
17311025hEGR1 is induced by EGF, inhibited by gefitinib in bladder cell lines and related to EGF receptor levels in bladder tumours.Br J Cancer2007https://conductscience.org/library/papers/17311025PubMed
16465195Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma.Br J Cancer2006https://conductscience.org/library/papers/16465195PubMed
15083203Gefitinib ('Iressa', ZD1839) inhibits the growth response of bladder tumour cell lines to epidermal growth factor and induces TIMP2.Br J Cancer2004https://conductscience.org/library/papers/15083203PubMed
12415079Epidermal growth factor receptor and bladder cancer.Postgrad Med J2002https://conductscience.org/library/papers/12415079PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
EGF1950PubTator's text mininghttps://conductscience.org/library/genes/1950NCBI Gene
MMP14312PubTator's text mininghttps://conductscience.org/library/genes/4312NCBI Gene
MMP24313PubTator's text mininghttps://conductscience.org/library/genes/4313NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9683296

GET https://conductscience.org/api/papers/v1/9683296/references?page=2